Interpretation of treatment changes in 6-minute walk distance in patients with COPD.

PubWeight™: 1.82‹?› | Rank: Top 3%

🔗 View Article (PMID 18550610)

Published in Eur Respir J on June 11, 2008

Authors

M A Puhan1, M J Mador, U Held, R Goldstein, G H Guyatt, H J Schünemann

Author Affiliations

1: Horten Centre, University Hospital of Zurich, Postfach Nord, CH-8091 Zurich, Switzerland. milo.puhan@usz.ch

Articles citing this

The minimal important difference of exercise tests in severe COPD. Eur Respir J (2010) 3.27

The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 3.24

The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve (2013) 1.63

Physical Activity Counselling during Pulmonary Rehabilitation in Patients with COPD: A Randomised Controlled Trial. PLoS One (2015) 1.56

Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol (2013) 1.30

Ataluren as an agent for therapeutic nonsense suppression. Annu Rev Med (2012) 1.24

Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease--practical issues: a Canadian Thoracic Society Clinical Practice Guideline. Can Respir J (2010) 1.10

Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting. Breast Cancer Res Treat (2011) 1.04

Internet-based dyspnea self-management support for patients with chronic obstructive pulmonary disease. J Pain Symptom Manage (2012) 1.02

Reference equations for the six-minute walk distance based on a Brazilian multicenter study. Braz J Phys Ther (2013) 1.01

Tai chi exercise for patients with chronic obstructive pulmonary disease: a pilot study. Respir Care (2010) 0.99

Daily step count predicts acute exacerbations in a US cohort with COPD. PLoS One (2013) 0.98

The clinical relevance of outcomes used in late-onset Pompe disease: can we do better? Orphanet J Rare Dis (2013) 0.93

Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy. Asian J Androl (2012) 0.92

Obesity and physical activity in the daily life of patients with COPD. Lung (2012) 0.90

Responsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPD. Pulm Med (2013) 0.89

Pulmonary rehabilitation program including respiratory conditioning for chronic obstructive pulmonary disease (COPD): Improved hyperinflation and expiratory flow during tidal breathing. J Thorac Dis (2012) 0.87

Construct validity and minimal important difference of 6-minute walk distance in survivors of acute respiratory failure. Chest (2015) 0.86

Impact of bronchodilator therapy on exercise tolerance in COPD. Int J Chron Obstruct Pulmon Dis (2010) 0.86

Reproducibility of the six-minute walk test and Glittre ADL-test in patients hospitalized for acute and exacerbated chronic lung disease. Braz J Phys Ther (2015) 0.85

Tasmanian Aborigines step up to health: evaluation of a cardiopulmonary rehabilitation and secondary prevention program. BMC Health Serv Res (2014) 0.84

Chronic obstructive pulmonary disease self-management activation research trial (COPD-SMART): design and methods. Contemp Clin Trials (2013) 0.84

Benefits of whole body vibration training in patients hospitalised for COPD exacerbations - a randomized clinical trial. BMC Pulm Med (2014) 0.83

Impact of pulmonary rehabilitation on quality of life and functional capacity in patients on waiting lists for lung transplantation. J Bras Pneumol (2013) 0.83

Concerns about exercise are related to walk test results in pulmonary rehabilitation for patients with COPD. Int J Behav Med (2012) 0.83

Health status measured by the Clinical COPD Questionnaire (CCQ) improves following post-acute pulmonary rehabilitation in patients with advanced COPD: a prospective observational study. NPJ Prim Care Respir Med (2014) 0.82

Whole-body vibration improves functional capacity and quality of life in patients with severe chronic obstructive pulmonary disease (COPD): a pilot study. Int J Chron Obstruct Pulmon Dis (2015) 0.82

Effects of Tai Chi on exercise capacity and health-related quality of life in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis (2014) 0.81

Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. PLoS One (2015) 0.81

Does the mode of exercise influence recovery of functional capacity in the early postoperative period after coronary artery bypass graft surgery? A randomized controlled trial. Interact Cardiovasc Thorac Surg (2012) 0.80

Six-minute stepper test: a valid clinical exercise tolerance test for COPD patients. Int J Chron Obstruct Pulmon Dis (2016) 0.79

Time to adapt exercise training regimens in pulmonary rehabilitation--a review of the literature. Int J Chron Obstruct Pulmon Dis (2014) 0.79

Medium term effects of including manual therapy in a pulmonary rehabilitation program for chronic obstructive pulmonary disease (COPD): a randomized controlled pilot trial. J Man Manip Ther (2016) 0.78

Chronic obstructive pulmonary disease (COPD) evidentiary framework. Ont Health Technol Assess Ser (2012) 0.78

Tai chi mind-body exercise in patients with COPD: study protocol for a randomized controlled trial. Trials (2014) 0.77

The Differential Impact of Emphysema on Respiratory Symptoms and 6-Minute Walk Distance in HIV Infection. J Acquir Immune Defic Syndr (2017) 0.77

Inspiratory muscle training in allogeneic hematopoietic stem cell transplantation recipients: a randomized controlled trial. Support Care Cancer (2015) 0.77

Noninvasive positive pressure ventilation for chronic respiratory failure patients with stable chronic obstructive pulmonary disease (COPD): an evidence-based analysis. Ont Health Technol Assess Ser (2012) 0.76

Transition of PH patients from sildenafil to tadalafil: feasibility and practical considerations. Lung (2012) 0.76

Minimal important improvement thresholds for the six-minute walk test in a knee arthroplasty cohort: triangulation of anchor- and distribution-based methods. BMC Musculoskelet Disord (2016) 0.75

A randomized controlled trial of telephone-mentoring with home-based walking preceding rehabilitation in COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75

Lung volume reduction surgery and pulmonary rehabilitation improve exercise capacity and reduce dyspnea during functional activities in people with emphysema. Cardiopulm Phys Ther J (2009) 0.75

Clinician's Commentary. Physiother Can (2010) 0.75

Smallest worthwhile effect of land-based and water-based pulmonary rehabilitation for COPD. ERJ Open Res (2015) 0.75

Minimal clinically important difference for the 6-min walk test: literature review and application to Morquio A syndrome. Orphanet J Rare Dis (2017) 0.75

Long-term Exercise After Pulmonary Rehabilitation (LEAP): Design and rationale of a randomized controlled trial of Tai Chi. Contemp Clin Trials (2015) 0.75

The minimal important difference of the pulmonary functional status and dyspnea questionnaire in patients with severe chronic obstructive pulmonary disease. Respir Res (2013) 0.75

A Lifestyle Physical Activity Intervention for Patients with Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. Ann Am Thorac Soc (2016) 0.75

The 6-minute Walk Test as a COPD Stratification Tool: Insights From the COPD Biomarker Qualification Consortium. Am J Respir Crit Care Med (2016) 0.75

Exercise training for asbestos-related and other dust-related respiratory diseases: a randomised controlled trial. BMC Pulm Med (2014) 0.75

Short-term and long-term effects of a self-managed physical activity program using a pedometer for chronic respiratory disease: a randomized controlled trial. J Phys Ther Sci (2017) 0.75

Articles by these authors

Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials (1989) 15.99

Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA (1994) 13.60

Guidelines for reading literature reviews. CMAJ (1988) 10.90

Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA (1994) 10.80

Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol (1994) 9.50

Development and validation of a questionnaire to measure asthma control. Eur Respir J (1999) 9.35

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol (1997) 9.01

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96

Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology. J Infect Dis (1990) 8.33

The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J (1985) 8.06

Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90

How to keep up with the medical literature: V. Access by personal computer to the medical literature. Ann Intern Med (1986) 7.36

Users' guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA (1993) 6.83

Measuring quality of life in children with asthma. Qual Life Res (1996) 6.76

A consumer's guide to subgroup analyses. Ann Intern Med (1992) 6.34

Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA (2000) 5.94

Measuring disease-specific quality of life in clinical trials. CMAJ (1986) 5.56

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax (1992) 5.37

Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19

Measuring quality of life in asthma. Am Rev Respir Dis (1993) 4.97

Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) 4.80

Randomised controlled trial of respiratory rehabilitation. Lancet (1994) 4.74

Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet (1996) 4.65

Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol (1996) 4.55

Validation of an index of the quality of review articles. J Clin Epidemiol (1991) 4.54

Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA (1988) 4.46

Effect of encouragement on walking test performance. Thorax (1984) 4.44

Practitioners of evidence based care. Not all clinicians need to appraise evidence from scratch but all need some skills. BMJ (2000) 4.41

The science of reviewing research. Ann N Y Acad Sci (1993) 4.15

Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med (1998) 4.01

Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J (1999) 4.00

Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med (1994) 3.89

Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA (2000) 3.87

Measuring quality of life in the parents of children with asthma. Qual Life Res (1996) 3.82

The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens (1999) 3.72

Canadian physicians' attitudes about and preferences regarding clinical practice guidelines. CMAJ (1997) 3.56

Users' guides to the medical literature. JAMA (1993) 3.56

The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36

Users' guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. Evidence-Based Medicine Working Group. JAMA (2000) 3.33

Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA (2001) 3.32

Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med (1997) 3.28

Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA (1996) 3.21

Intention-to-treat principle. CMAJ (2001) 3.20

Drinking water turbidity and gastrointestinal illness in the elderly of Philadelphia. J Epidemiol Community Health (2000) 3.15

Determinants in Canadian health care workers of the decision to withdraw life support from the critically ill. Canadian Critical Care Trials Group. JAMA (1995) 3.08

Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intern Med (1998) 3.07

Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology (1992) 3.06

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS (1999) 3.04

Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol (1997) 2.98

Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA (1996) 2.98

How to keep up with the medical literature: I. Why try to keep up and how to get started. Ann Intern Med (1986) 2.94

When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment. J Clin Epidemiol (2001) 2.84

Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1992) 2.81

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy (1991) 2.80

A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas (1996) 2.74

Effects of higher- versus lower-protein diets on health outcomes: a systematic review and meta-analysis. Eur J Clin Nutr (2012) 2.72

Residents' experiences of abuse, discrimination and sexual harassment during residency training. McMaster University Residency Training Programs. CMAJ (1996) 2.71

Reamed versus nonreamed intramedullary nailing of lower extremity long bone fractures: a systematic overview and meta-analysis. J Orthop Trauma (2000) 2.69

The rational clinical examination. Is this patient having a myocardial infarction? JAMA (1998) 2.66

A Prothrombin Conversion Accelerator in Serum. Science (1949) 2.64

How should we measure function in patients with chronic heart and lung disease? J Chronic Dis (1985) 2.61

User's guide to the orthopaedic literature: how to use an article about a surgical therapy. J Bone Joint Surg Am (2001) 2.58

Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group. JAMA (1998) 2.52

Clinical recommendations using levels of evidence for antithrombotic agents. Chest (1995) 2.52

Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 2.50

An index of scientific quality for health reports in the lay press. J Clin Epidemiol (1993) 2.47

Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis (1998) 2.43

Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care (2001) 2.36

Sensitivity to change of the Roland-Morris Back Pain Questionnaire: part 1. Phys Ther (1998) 2.35

Treatment of open fractures of the shaft of the tibia. J Bone Joint Surg Br (2001) 2.33

Selective decontamination of the digestive tract. An overview. Chest (1994) 2.28

Selective paralysis of voluntary but not limbically influenced automatic respiration. Arch Neurol (1991) 2.27

Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA (1993) 2.26

A framework for clinical evaluation of diagnostic technologies. CMAJ (1986) 2.26

Agreement among reviewers of review articles. J Clin Epidemiol (1991) 2.25

Practice guidelines. What are internists looking for? J Gen Intern Med (1996) 2.17

Should study subjects see their previous responses? J Chronic Dis (1985) 2.17

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16

PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest (1999) 2.14

Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun (1989) 2.12

Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions. ACP J Club (1996) 2.10

Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA (1996) 2.08

How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03

Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy (2009) 1.97

Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA (1999) 1.96

Restriction fragment length polymorphisms among uropathogenic Escherichia coli isolates: pap-related sequences compared with rrn operons. Infect Immun (1990) 1.95

Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol (1988) 1.93

Users' guides to the medical literature. XI. How to use an article about a clinical utilization review. Evidence-Based Medicine Working Group. JAMA (1996) 1.91

Long-term effects of outpatient rehabilitation of COPD: A randomized trial. Chest (2000) 1.91

Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax (2001) 1.89

Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology (2000) 1.86

Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis (1987) 1.85

Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group. JAMA (1999) 1.84

Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome. Am J Respir Crit Care Med (2000) 1.81

Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum (1993) 1.80

FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. Transplantation (1994) 1.80

Stimulation of human leukocyte thromboplastic activity by endotoxin. Proc Soc Exp Biol Med (1971) 1.79

The diagnosis of dementia. CMAJ (1987) 1.76